ChartMill · Oct 21, 2026
After-Hours US Movers: STAK, NCPL, CRMT Gain; NVEC, HKPD, LHSW Fall
After-hours US movers: STAK, NCPL and CRMT led gainers, while NVEC, HKPD and LHSW led losers in extended trading.
HK
NASDAQ · HKPD
Hong Kong Pharma Digital Technology Holdings Limited
Industrials · Integrated Freight & Logistics
$1.94
Down-$0.09 (-4.64%)
Updated Nov 4, 2026, 11:10 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8.62M
- P/E ratio
- -299.74
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $2.42
- Volume
- 16.81K
- Avg. volume
- 166.7K
Price performance · HKPD
HKPD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
HKPD closed at $1.94 after 21 trading sessions, up 1785.33% for the selected period.
- Last close
- $1.94
- Period change
- +1785.33%
- Period low
- $0.10
- Period high
- $2.24
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.94 | $2.00 | $1.74 | $1.94 | 16.81K |
| Nov 2, 2026 | $1.93 | $1.9842 | $1.81 | $1.83 | 11.21K |
| Oct 30, 2026 | $2.12 | $2.124 | $1.84 | $1.98 | 27.11K |
| Oct 29, 2026 | $2.1881 | $2.19 | $2.1304 | $2.19 | 9.89K |
| Oct 28, 2026 | $2.18 | $2.4195 | $2.1063 | $2.18 | 59.36K |
| Oct 27, 2026 | $2.13 | $2.3995 | $2.0844 | $2.14 | 90.39K |
| Oct 26, 2026 | $2.09 | $2.24 | $1.83 | $2.19 | 133.75K |
| Oct 23, 2026 | $1.94 | $2.20 | $1.724 | $2.00 | 77.15K |
| Oct 22, 2026 | $1.82 | $1.984 | $1.70 | $1.92 | 277.77K |
| Oct 21, 2026 | $1.796 | $2.196 | $1.628 | $2.04 | 145.56K |
| Oct 20, 2026 | $2.20 | $2.24 | $2.112 | $2.24 | 8.03K |
| Oct 19, 2026 | $0.108 | $0.1155 | $0.1027 | $0.1122 | 254.1K |
| Oct 16, 2026 | $0.112 | $0.112 | $0.1005 | $0.1102 | 266.24K |
| Oct 15, 2026 | $0.103 | $0.1106 | $0.1002 | $0.1099 | 153.76K |
| Oct 14, 2026 | $0.1049 | $0.113 | $0.0962 | $0.113 | 255.87K |
| Oct 13, 2026 | $0.1014 | $0.1066 | $0.1012 | $0.1049 | 67.78K |
| Oct 12, 2026 | $0.111 | $0.1136 | $0.1031 | $0.1066 | 241.16K |
| Oct 9, 2026 | $0.0962 | $0.1137 | $0.095 | $0.112 | 388.78K |
| Oct 8, 2026 | $0.098 | $0.1008 | $0.095 | $0.1008 | 604.01K |
| Oct 7, 2026 | $0.0998 | $0.1059 | $0.0957 | $0.1037 | 431.28K |
| Oct 6, 2026 | $0.103 | $0.1072 | $0.10 | $0.1029 | 545.58K |
Latest HKPD news
The latest Smart Investors Daily articles mentioning HKPD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HKPD research
Overview
Company profile and research snapshot.
Company profile
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Oct 21, 2026
12 Industrials Stocks Moving In Wednesday's Intraday Session
Gainers SVRN (NASDAQ:SVRN) shares increased by 43.2% to $37.21 during Wednesday's regular session. The market value of their outstanding shares is at $49.7 million. Olenox Industries (NASDAQ:OLOX) shares rose
Yahoo · Oct 21, 2026
Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split
HONG KONG, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over-the-counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it expects to implement a 1-for-20 reverse stock split, or consolidation of its issued and unissued Class A ordinary shares and Class B ordinary shares, par value $0.001 per share (the “Ordinary Shares”), effective at the opening of market of October 26,
Benzinga · Oct 21, 2026
Cellyan Biotechnology Announces 1-For-20 Reverse Stock Split, Effective Oct. 26
Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over-the-counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
